Wilson Sonsini has advised Enliven Therapeutics. Cooley has advised the underwriters. Enliven Therapeutics, Inc. (Enliven) (Nasdaq: ELVN) a clinical-stage biopharmaceutical company, has closed its upsized underwritten...
Enliven Therapeutics Closes $460 Million Upsized Public Offering
Resmed Acquires Noctrix Health for $340 Million to Expand Sleep Health Portfolio
DLA Piper has advised Resmed. Wilson Sonsini Goodrich & Rosati has advised Noctrix Health. Resmed has completed the acquisition of Noctrix Health, Inc. for $340 million,...